ARTICLE | Financial News
BiondVax prices $10M follow-on
September 22, 2017 8:19 PM UTC
Flu vaccine company BiondVax Pharmaceuticals Ltd. (Tel Aviv:BVXV; NASDAQ:BVXV) raised $10 million through the sale of 1.7 million American Depositary Shares (ADS) at $6 in a follow-on underwritten by ...
BCIQ Company Profiles